Compounds > ketoconazole

ketoconazole and phosphorylcholine

ketoconazole has been researched along with phosphorylcholine in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clark, JE; Harder, DR; Kauser, K; Ma, YH; Masters, BS; Ortiz de Montellano, PR; Roman, RJ1
Birchmore, JL; Hanson, PK; Malone, L; Nichols, JW1
Barbosa, HS; de Castro, SL; Lira, R; Santa-Rita, RM; Urbina, JA1
Berman, J1
Fedorko, DP; Mahanty, S; Nash, TE; Ramanathan, R; Talaat, KR1
Bavchvarov, BI; Campillo, M; Castanys, S; Gamarro, F; López-Martín, C; Martínez-García, M; Pérez-Victoria, JM; Torrecillas, IR1
Bajpai, P; Gupta, S; Sane, SA; Shakya, N; Vishwakarma, P1
Jiang, J; Mathur, R; Pandharkar, T; Schmittgen, TD; Shaha, C; Werbovetz, KA; Zhu, X1
Heli, H; Karimian, K; Motazedian, MH; Nazari-Vanani, R; Sattarahmady, N; Sharifi, F; Vais, RD1

Reviews

1 review(s) available for ketoconazole and phosphorylcholine

ArticleYear
Clinical status of agents being developed for leishmaniasis.
    Expert opinion on investigational drugs, 2005, Volume: 14, Issue:11

    Topics: Aminoquinolines; Antiprotozoal Agents; Fluconazole; Humans; Imiquimod; Ketoconazole; Leishmaniasis; Paromomycin; Phosphorylcholine

2005

Other Studies

8 other study(ies) available for ketoconazole and phosphorylcholine

ArticleYear
Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries.
    Circulation research, 1991, Volume: 68, Issue:4

    Topics: Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Dogs; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Hydrazines; Indomethacin; Ketoconazole; Kinetics; Muscle, Smooth, Vascular; Phospholipases A; Phospholipases A2; Phosphorylcholine; Proadifen; Renal Artery; Triazoles

1991
Lem3p is essential for the uptake and potency of alkylphosphocholine drugs, edelfosine and miltefosine.
    The Journal of biological chemistry, 2003, Sep-19, Volume: 278, Issue:38

    Topics: Alleles; Antiprotozoal Agents; Biological Transport; Cell Division; Cell Membrane; Cycloheximide; Dose-Response Relationship, Drug; Drug Resistance; Drug Resistance, Multiple; Endocytosis; Gene Deletion; Ketoconazole; Leishmaniasis; Lipid Metabolism; Lysophosphatidylcholines; Membrane Transport Proteins; Microscopy, Fluorescence; Mutation; Nuclear Envelope; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylserines; Phosphodiesterase Inhibitors; Phospholipid Ethers; Phosphorylcholine; Point Mutation; Protein Structure, Tertiary; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Time Factors

2003
Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:5

    Topics: Animals; Chlorocebus aethiops; Drug Synergism; Drug Therapy, Combination; Ergosterol; Ketoconazole; Lysophospholipids; Microscopy, Electron; Microscopy, Electron, Scanning; Parasitic Sensitivity Tests; Phospholipid Ethers; Phosphorylcholine; Trypanocidal Agents; Trypanosoma cruzi; Vero Cells

2005
A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis.
    The American journal of tropical medicine and hygiene, 2011, Volume: 84, Issue:1

    Topics: Adult; Aged; Amphotericin B; Antiprotozoal Agents; Child; Female; Humans; Ketoconazole; Leishmania; Leishmaniasis, Cutaneous; Male; Middle Aged; Phosphorylcholine; Species Specificity

2011
Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8

    Topics: Aminoquinolines; Antimony; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Drug Resistance, Bacterial; Ketoconazole; Leishmania tropica; Leishmaniasis; Phosphorylcholine; Protein Binding

2011
Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator-Picroliv.
    Acta tropica, 2011, Volume: 119, Issue:2-3

    Topics: Animals; Antiprotozoal Agents; Cinnamates; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Female; Glycosides; Hydrogen Peroxide; Immunologic Factors; Ketoconazole; Leishmania donovani; Leishmaniasis, Visceral; Male; Phagocytosis; Phosphorylcholine; Reactive Nitrogen Species; Reactive Oxygen Species; Rodent Diseases; Treatment Outcome; Vanillic Acid

2011
Studies on the antileishmanial mechanism of action of the arylimidamide DB766: azole interactions and role of CYP5122A1.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8

    Topics: Amidines; Animals; Antiprotozoal Agents; Axenic Culture; Blotting, Western; Cricetinae; Drug Combinations; Drug Resistance; Drug Synergism; Furans; Gene Expression Regulation; Ketoconazole; Leishmania donovani; Life Cycle Stages; Mice; Phosphorylcholine; Protozoan Proteins; Sterol 14-Demethylase; Triazoles

2014
Investigation of anti-leishmanial efficacy of miltefosine and ketoconazole loaded on nanoniosomes.
    Acta tropica, 2018, Volume: 185

    Topics: Animals; Antiprotozoal Agents; Ketoconazole; Leishmania major; Leishmaniasis, Cutaneous; Nanostructures; Phosphorylcholine

2018